Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1025097-10-2
2. Act-179811
3. 2oea2un10y
4. 1-cyclopropyl-6-fluoro-7-[4-[[2-fluoro-4-[(5r)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl]-4-hydroxypiperidin-1-yl]-4-oxoquinoline-3-carboxylic Acid
5. 1-cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-((r)-5-hydroxymethyl-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
6. Cadazolid [inn]
7. Cadazolid [usan:inn]
8. Unii-2oea2un10y
9. Cadazolid (usan/inn)
10. Cadazolid [usan]
11. Cadazolid [who-dd]
12. Schembl541618
13. Cadazolid (act-179811)
14. Chembl3707376
15. Gtpl10767
16. Dtxsid10145234
17. Bcp20623
18. Ex-a1438
19. Act179811
20. Cs-6972
21. Db11847
22. Ac-35473
23. Hy-100436
24. J3.437.086i
25. D11207
26. A900061
27. Q15408418
28. (r)-1-cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
29. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-((5r)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)-4-hydroxy-1-piperidinyl)-1,4-dihydro-4-oxo-
30. Jjh
| Molecular Weight | 585.6 g/mol |
|---|---|
| Molecular Formula | C29H29F2N3O8 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 585.19227122 g/mol |
| Monoisotopic Mass | 585.19227122 g/mol |
| Topological Polar Surface Area | 140 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Clostridium difficile infection
Market Place
ABOUT THIS PAGE
10
PharmaCompass offers a list of Cadazolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cadazolid manufacturer or Cadazolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cadazolid manufacturer or Cadazolid supplier.
PharmaCompass also assists you with knowing the Cadazolid API Price utilized in the formulation of products. Cadazolid API Price is not always fixed or binding as the Cadazolid Price is obtained through a variety of data sources. The Cadazolid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cadazolid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cadazolid, including repackagers and relabelers. The FDA regulates Cadazolid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cadazolid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cadazolid supplier is an individual or a company that provides Cadazolid active pharmaceutical ingredient (API) or Cadazolid finished formulations upon request. The Cadazolid suppliers may include Cadazolid API manufacturers, exporters, distributors and traders.
Cadazolid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cadazolid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cadazolid GMP manufacturer or Cadazolid GMP API supplier for your needs.
A Cadazolid CoA (Certificate of Analysis) is a formal document that attests to Cadazolid's compliance with Cadazolid specifications and serves as a tool for batch-level quality control.
Cadazolid CoA mostly includes findings from lab analyses of a specific batch. For each Cadazolid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cadazolid may be tested according to a variety of international standards, such as European Pharmacopoeia (Cadazolid EP), Cadazolid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cadazolid USP).
